Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics.
Financial Statements
- Click here to download Incyte Corp.'s Income Statement
- Click here to download Incyte Corp.'s Balance Sheet
- Click here to download Incyte Corp.'s Statement of Cash Flows
Key Info
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Sector: Professional, Scientific, and Technical Services
- CEO Name:
Key Statistics
- Stock Price: $84.13
- Dividend Yield: 0%
- Market Capitalization: $18,627,518,502
- Shares Outstanding: 219,923,477
- Number of Employees: 0
- Trailing 12-Month EPS: $2.18
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-08-03
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $84.13
- 52-week high: $110.37
- 52-week low: $75.52
- 200-day moving average: $84.62
- 50-day moving average: $83.74
Performance
- 1-Month Price Return: 1.1%
- 3-Month Price Return: 4.4%
- 6-Month Price Return: -1.4%
- 1-Year Price Return: -17.3%
- 2-Year Price Return: -0.3%
- 5-Year Price Return: 7.6%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast